Diabetic Kidney Disease (DKD) Worsens CV Outcomes after First-Ever Major Cardiovascular Event in Type 2 Diabetes (T2D)

被引：0
|
作者：
Garofolo, Monia
Lucchesi, Daniela
Giambalvo, Massimo
Capobianco, Martina
Francesconi, Paolo
Penno, Giuseppe
Del Prato, Stefano
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-424-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
424-P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Diabetic Kidney Disease (DKD) in UK Patients With Type 2 Diabetes (T2D)
    Ruzafa, Javier Cid
    Paczkowski, Rosirene
    Boye, Kristina S.
    Di Tanna, Gian Luca
    Sheetz, Matthew J.
    Donaldson, Robert
    Breyer, Matthew D.
    Neasham, David
    Voelker, James R.
    DIABETES, 2013, 62 : A397 - A397
  • [2] Design of the Empagliflozin Cardiovascular (CV) Outcome Event Trial in Type 2 Diabetes (T2D)
    Zinman, Bernard
    Inzucchi, Silvio E.
    Lachin, John M.
    Wanner, Christoph
    Ferrari, Roberto
    Bluhmki, Erich
    Hantel, Stefan
    Johansen, Odd Erik
    Woerle, Hans-Juergen
    Broedl, Uli C.
    DIABETES, 2013, 62 : A600 - A600
  • [3] ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN
    Willis, M.
    Durkin, M.
    Neslusan, C.
    Traina, S.
    Nilsson, A.
    VALUE IN HEALTH, 2020, 23 : S112 - S112
  • [4] Effect of Surgical vs. Medical Therapy on Diabetic Kidney Disease (DKD) in Severely Obese Adolescents with Type 2 Diabetes (T2D)
    Bjornstad, Petter
    Hughan, Kara S.
    Kelsey, Megan M.
    Shah, Amy
    Lynch, Jane L.
    Nehus, Edward
    Mitsnefes, Mark
    Jenkins, Todd M.
    Xu, Peixin
    Xie, Changchun
    Inge, Thomas H.
    Nadeau, Kristen J.
    DIABETES, 2019, 68
  • [5] Diabetic Kidney Disease (DKD) and Nonalcoholic Fatty Liver Disease (NAFLD) Confer Worsening All-Cause Mortality and Cardiovascular Disease (CVD) Risk in Type 2 Diabetes (T2D)
    Garofolo, Monia
    Lucchesi, Daniela
    Giambalvo, Massimo
    Capobianco, Martina
    Francesconi, Paolo
    Penno, Giuseppe
    Del Prato, Stefano
    DIABETES, 2023, 72
  • [6] Cardiovascular (CV) and Hypoglycemia Outcomes across Age Groups in People with Type 2 Diabetes (T2D) in the CAROLINA Trial
    Espeland, Mark
    Pratley, Richard E.
    Rosenstock, Julio
    Kadowaki, Takashi
    Seino, Yutaka
    Zinman, Bernard
    Marx, Nikolaus
    Mcguire, Darren K.
    Andersen, Knut R.
    Mattheus, Michaela
    Keller, Annett
    Johansen, Odd Erik
    DIABETES, 2020, 69
  • [7] Electrochemical Skin Conductance (ESC) Associates with Diabetic Kidney Disease (DKD) in European Americans (EAs) and African Americans (AAs) with Type 2 Diabetes Mellitus (T2D)
    Freedman, Barry I.
    Smith, Susan C.
    Bagwell, Benjamin M.
    Xu, Jianzhao
    Bowden, Donald W.
    Divers, Jasmin
    DIABETES, 2015, 64 : A157 - A157
  • [8] Cardiovascular (CV) Risk Evaluation in People with Type 2 Diabetes (T2D) on Insulin Therapy (CREDIT) Study-CV Disease and CV Risk at Baseline
    Freemantle, Nick
    Balkau, Beverley
    Danchin, Nicolas
    Admane, Karim
    Marre, Michel
    Home, Philip
    Blonde, Lawrence
    DIABETES, 2009, 58 : A126 - A126
  • [9] Delayed Chronic Kidney Disease (CKD) Diagnosis in Type 2 Diabetes (T2D)
    Harindhanavudhi, Tasma
    Freese, Rebecca L.
    Caramori, Luiza
    DIABETES, 2021, 70
  • [10] HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)
    Balijepalli, C.
    Desai, K.
    Yan, K.
    Zoratti, M.
    Marshall, L.
    White, N.
    Franklin, M.
    VALUE IN HEALTH, 2019, 22 : S572 - S572
12345